You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Citation Tools

Article menu
Commentary
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ardizzoni A, Azevedo S, Rubio-Viqueira B, et al
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2022;10:e005581. doi: 10.1136/jitc-2022-005581